Details for New Drug Application (NDA): 010670
✉ Email this page to a colleague
NDA 010670 describes ORINASE, which is a drug marketed by Pharmacia And Upjohn and is included in two NDAs. Additional details are available on the ORINASE profile page.
The generic ingredient in ORINASE is tolbutamide sodium. There are fifteen drug master file entries for this compound. Additional details are available on the tolbutamide sodium profile page.
The generic ingredient in ORINASE is tolbutamide sodium. There are fifteen drug master file entries for this compound. Additional details are available on the tolbutamide sodium profile page.
Summary for 010670
| Tradename: | ORINASE |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | tolbutamide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 010670
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
